Top 10 Biologics Trade Shows in Switzerland 2026

User avatar placeholder
Written by Robert Gultig

5 January 2026

Introduction:

The pharmaceutical industry in Switzerland continues to thrive, with a strong focus on biologics. In 2026, Switzerland remains a key player in the global biologics market, with a significant presence in various trade shows. The country’s expertise in biologics manufacturing, research, and development has positioned it as a hub for innovation in this sector. With a growing demand for biologics worldwide, Switzerland’s top trade shows play a crucial role in showcasing the latest advancements and fostering collaborations within the industry.

Top 10 Biologics Trade Shows in Switzerland 2026:

1. Bio International Convention – Held in Basel, Switzerland, this annual event attracts over 16,000 attendees from around the world. With a focus on biopharmaceuticals and biotechnology, it serves as a platform for networking and knowledge sharing among industry professionals.

2. Swiss Biotech Day – As the largest biotech conference in Switzerland, Swiss Biotech Day brings together over 600 participants each year. The event highlights the latest trends and innovations in biologics research and development.

3. BIO-Europe Spring – Taking place in Zurich, this event is a key meeting point for biotech and pharmaceutical companies seeking partnerships and investment opportunities. With over 2,500 attendees, it provides a valuable platform for business development in the biologics sector.

4. European Biotech Week – Held in Geneva, this week-long event showcases the diversity of the biotech industry in Europe. With over 800 activities across the continent, it promotes public awareness and engagement with biologics research and innovation.

5. Swiss Biotech Association Annual Conference – This conference brings together industry leaders, researchers, and policymakers to discuss the latest trends and challenges in biologics development. With over 300 participants, it plays a significant role in shaping the future of the biotech sector in Switzerland.

6. Basel Life – An international life sciences conference held in Basel, Basel Life covers a wide range of topics, including biologics, genetics, and personalized medicine. With over 3,000 participants, it is a key event for networking and collaboration in the biologics industry.

7. Swiss Biotech Investor Day – This event brings together investors and biotech companies to explore investment opportunities in the sector. With over CHF 100 million in funding raised in 2025, the Swiss Biotech Investor Day is a crucial platform for financing biologics innovation.

8. Swiss Biotech Showcase – Held in Lausanne, this event highlights the latest advancements in Swiss biotech and provides a platform for companies to showcase their products and services. With over 50 exhibitors, it offers valuable networking opportunities for industry professionals.

9. Zurich Life Sciences Day – This event focuses on the life sciences sector in Zurich, with a particular emphasis on biologics research and development. With over 400 participants, it serves as a platform for collaboration and knowledge exchange in the industry.

10. Biotech Week Boston – Although not based in Switzerland, Biotech Week Boston is a key event for Swiss biotech companies looking to expand their presence in the US market. With over 3,000 attendees, it provides valuable opportunities for partnership and growth in the biologics sector.

Insights:

The biologics market in Switzerland is expected to continue growing in the coming years, driven by increasing demand for innovative treatments and therapies. With a strong focus on research and development, Switzerland remains at the forefront of biologics innovation, attracting investment and partnerships from around the world. As the country’s top trade shows continue to showcase the latest advancements in biologics, Switzerland is well-positioned to maintain its leadership in the global biotech industry. With a commitment to excellence and collaboration, Swiss biotech companies are poised for continued success in the dynamic and competitive biologics market.

Related Analysis: View Previous Industry Report

Author: Robert Gultig in conjunction with ESS Research Team

Robert Gultig is a veteran Managing Director and International Trade Consultant with over 20 years of experience in global trading and market research. Robert leverages his deep industry knowledge and strategic marketing background (BBA) to provide authoritative market insights in conjunction with the ESS Research Team. If you would like to contribute articles or insights, please join our team by emailing support@essfeed.com.
View Robert’s LinkedIn Profile →